Concepedia

Aleksandra Stańczak

AS

Statistics

Publications

6

Citations

292

H-Index

6

Active since

2011

Affiliations

Celon Pharma (Poland)(Current)

Medical University of Lodz

Gdańsk Medical University

Aleksandra Stańczak is an author at Celon Pharma (Poland) specializing in molecular oncology, oncology, and medicine.

Publications per year

2011–2022

6

Publications

6

Wnt/β-catenin pathway as a potential prognostic and predictive marker in patients with advanced ovarian cancer

Lubomir Bodnar, Aleksandra Stańczak, Szczepan Cierniak et al. · Journal of Ovarian Research · 2014 · 81 citations · Full text

, , +17

Prognostic Significance of Wnt-1, β-catenin and E-cadherin Expression in Advanced Colorectal Carcinoma

Aleksandra Stańczak, Lubomir Bodnar, Wojciech Olszewski et al. · Pathology & Oncology Research · 2011 · 77 citations · Full text

, , +17

Epithelial–mesenchymal transition confers resistance to selective FGFR inhibitors in SNU-16 gastric cancer cells

Paulina Grygielewicz, Barbara Dymek, Anna Bujak et al. · Gastric Cancer · 2014 · 71 citations · Full text

, , +17

MET-Pyk2 Axis Mediates Acquired Resistance to FGFR Inhibition in Cancer Cells

Kamila Kitowska, Monika Gorska‐Arcisz, Dima Antoun et al. · Frontiers in Oncology · 2021 · 43 citations · Full text

, , +17

p38 Mediates Resistance to FGFR Inhibition in Non-Small Cell Lung Cancer

Izabela Zarczynska, Monika Gorska‐Arcisz, Alexander Jorge Cortez et al. · Cells · 2021 · 10 citations · Full text

, , +16

1–5 of 6